A low-oxygenic niche in bone marrow limits reactive oxygen species (ROS) production, thus providing long-term protection for hematopoietic stem cells (HSCs) from ROS stress. Although many approaches have been used to enrich HSCs, none has been designed to isolate primitive HSCs located within the lowoxygenic niche due to difficulties of direct physical access. Here we show that an early HSC population that might reside in the niche can be functionally isolated by taking advantage of the relative intracellular ROS activity. Many attributes of primitive HSCs in the low-oxygenic osteoblastic niche, such as quiescence, and calcium receptor, N-cadherin, Notch1, and p21 are higher in the ROS low population. Intriguingly, the ROS low population has a higher self-renewal potential. In contrast, significant HSC exhaustion in the ROS high population was observed following serial transplantation, and expression of activated p38 mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR) was higher in this population. Importantly, treatment with an antioxidant, a p38 inhibitor, or rapamycin was able to restore HSC function in the ROS high population. Thus, more potent HSCs associated with the lowoxygenic niche can be isolated by selecting for the low level of ROS expression.
IntroductionStem cells have a unique mechanism to cope with the cumulative reactive oxygen species (ROS) load, which involves increased antioxidant defenses and unique redox-dependent effects on growth and differentiation. [1][2][3][4][5] Hematopoietic stem cells (HSCs) and the supporting cells of the stem-cell niche are predominantly located in a low-oxygen milieu of the bone marrow, which allows long-term protection from ROS-related oxidative stress. 4,6,7 In the osteoblastic niche, the lowest end of an oxygen gradient within the bone marrow, 6,[8][9][10] HSCs remain quiescent and in contact with osteoblasts, 11 whereas in the relatively more oxygenic vascular niche, due to the proximity to blood circulation, stem cells actively proliferate and differentiate, [12][13][14][15] which might increase the intracellular ROS level. 1 In the osteoblastic niche, the calcium-sensing receptor (CaR) plays a critical role in localizing HSCs to the endosteal surface, although it does not affect HSC homing, 16 and osteoblast-derived factors have been suggested to improve survival of umbilical cord-derived HSCs under hypoxic conditions. 10 HSCs have been enriched using a variety of techniques, including cell-surface antigen selection, 17 elutriation, 18 pharmacologic manipulation, 19 and supravital dye, 20 as well as intracellular enzyme content. 21 However, none of these methods was designed to isolate quiescent HSCs located within the osteoblastic niche, which is generally considered to house the most primitive HSCs. 6,[8][9][10][11]14,22,23 Since it is difficult to experimentally access viable cells within the osteoblastic niche, these HSCs have not been directly or indirectly isolated by taking advantage of any of the specific properties of ...